Revolution Medicines (RVMD)
Develops RAS(ON) therapeutics for KRAS-driven and broad RAS-driven solid tumors.
$192.13
vs last close−0.63 (−0.33%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 97.27% | 208.48M shares | |
|---|---|---|---|
| 735 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 2.06% | 4.42M shares | |
| 17 holders · as of Sep 18, 2026 | |||
| Strategic holders | 5.01% | 10.74M shares | |
| 1 holder · as of Aug 13, 2026 | |||
| Adds to | 104.34% | ||
214.34M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 104.34%; nothing is left for Other.
13F, as of Jun 30, 2026
735 holders · 208.48M shares · 247 new positions · 488 increased · 155 reduced · 66 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 13.70M | 6.39% | +2.48M | Aug 7, 2026 |
| Farallon Capital Management LLC | 13.55M | 6.32% | −54.0K | Aug 14, 2026 |
| FMR LLC | 12.20M | 5.69% | +3.74M | Aug 13, 2026 |
| Baker Bros. Advisors LP | 11.44M | 5.34% | +1.89M | Aug 14, 2026 |
| Jupiter Topco LLC | 10.74M | 5.01% | +10.74Mnew | Aug 14, 2026 |
| Darwin Global Management, Ltd. | 10.63M | 4.96% | +8.42M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 9.09M | 4.24% | +726.4K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 8.29M | 3.87% | +792.2K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.70% | 12.20M | 13G | Jul 29, 2026 |
| Baker Bros. Advisors LP | 5.30% | 11.44M | 13G | Aug 14, 2026 |
| JANUS HENDERSON GROUP Ltd. | 5.10% | 10.74M | 13G | Aug 13, 2026 |
| FMR LLC | 5.00% | 9.40M | 13G | Nov 5, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 16, 2026 | Stephen Michael Kelseyofficer: See Remarks | Sale · 2 lots | 5,569 | $199.24 | 286,307 |
| Sep 16, 2026 | Anthony Manciniofficer: See Remarks | Sale · 2 lots | 1,774 | $199.24 | 42,116 |
| Sep 16, 2026 | Alan B. Sandlerofficer: Chief Development Officer | Sale · 2 lots | 341 | $199.24 | 52,868 |
| Sep 16, 2026 | Jack Andersofficer: Chief Financial Officer | Sale · 2 lots | 4,053 | $199.24 | 119,216 |
| Sep 16, 2026 | Jeff Cisliniofficer: SVP & General Counsel | Sale · 2 lots | 3,366 | $199.24 | 52,541 |
| Sep 16, 2026 | Mark A. Goldsmithdirector, officer: See Remarks | Sale · 2 lots | 13,988 | $199.24 | 253,342 |
| Sep 16, 2026 | Margaret A. Hornofficer: Chief Operating Officer | Sale · 2 lots | 4,967 | $199.24 | 149,680 |
| Sep 11, 2026 | Stephen Michael Kelseyofficer: See Remarks | Sale · 8 lots | 92,531 | $202.36 | 291,876 |
| Sep 10, 2026 | Anthony Manciniofficer: See Remarks | Sale · 5 lots | 15,448 | $204.16 | 43,890 |
| Sep 8, 2026 | Lorence H. Kimdirector | Sale · 7 lots | 17,090 | $209.82 | 0 |
House and Senate disclosures
Not reported.